Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy

Cancer Cell - United States
doi 10.1016/j.ccell.2018.09.003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Complement C5a-Mediated TAM-ing of Antitumor Immunity Drives Squamous Carcinogenesis

Cancer Cell
Cancer ResearchOncologyCell Biology
2018English

Radiation Fosters Dose-Dependent and Chemotherapy-Induced Immunogenic Cell Death

OncoImmunology
OncologyAllergyImmunology
2014English

Complement Factor C5a and C5a Receptor Contribute to Morphine Tolerance and Withdrawal-Induced Hyperalgesia in Rats

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2012English

Immune Cell-Derived C3a and C5a Costimulate Human T Cell Alloimmunity

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2013English

Differential Effects of the Complement Peptides, C5a and C5a Des Arg on Human Basophil and Lung Mast Cell Histamine Release.

Journal of Clinical Investigation
Medicine
1988English

In Vitro Chemosensitivity Profile of Oral Squamous Cell Cancer and Its Correlation With Clinical Response to Chemotherapy

Indian Journal of Cancer
Oncology
2007English

Complement Component 5a (C5A; C5); Complement 5a Receptor 1 (C5AR1)

Science-Business eXchange
2008English

Targeting CDC7 Improves Sensitivity to Chemotherapy of Esophageal Squamous Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2018English

EGFR Modulates Complement Activation in Head and Neck Squamous Cell Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy